Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.S. Market Analysis & Valuation

UpdatedJun 07, 2026
DataAggregated Company Financials
Companies7794
  • 7D-2.8%
  • 3M8.9%
  • 1Y22.8%
  • YTD7.2%

Over the last 7 days, the market has dropped 2.9%, driven by a decline of 5.3% in the Information Technology sector. As for the longer term, the market has actually risen by 23% in the last year. Looking forward, earnings are forecast to grow by 17% annually.

Trending IndustriesOil and GasGoldBiotechSoftwareRenewable Energy

Market Valuation and Performance

Has the U.S. Market valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 07 Jun 2026US$77.5tUS$24.3tUS$2.5t18.7x31.4x3.2x
Tue, 05 May 2026US$76.0tUS$24.0tUS$2.4t19.1x31.5x3.2x
Thu, 02 Apr 2026US$68.6tUS$23.7tUS$2.3t18.4x29.7x2.9x
Sat, 28 Feb 2026US$72.7tUS$23.7tUS$2.3t19.4x31.6x3.1x
Mon, 26 Jan 2026US$72.7tUS$23.2tUS$2.3t19.3x31.8x3.1x
Wed, 24 Dec 2025US$72.6tUS$23.2tUS$2.3t19.1x31.7x3.1x
Fri, 21 Nov 2025US$69.3tUS$23.1tUS$2.3t17.7x30.4x3x
Sun, 19 Oct 2025US$70.3tUS$22.7tUS$2.2t18.6x31.9x3.1x
Tue, 16 Sep 2025US$69.7tUS$22.9tUS$2.2t19.1x31.9x3x
Thu, 14 Aug 2025US$67.6tUS$23.0tUS$2.2t19.2x31.2x2.9x
Sat, 12 Jul 2025US$65.5tUS$22.5tUS$2.1t18.8x31.2x2.9x
Mon, 09 Jun 2025US$62.6tUS$22.5tUS$2.1t17.9x29.8x2.8x
Wed, 07 May 2025US$58.7tUS$22.0tUS$2.1t17.2x28.1x2.7x
Fri, 04 Apr 2025US$58.4tUS$21.9tUS$2.1t16.7x28.5x2.7x
Sun, 02 Mar 2025US$62.3tUS$21.9tUS$2.0t17.8x30.5x2.8x
Tue, 28 Jan 2025US$63.7tUS$22.0tUS$2.0t18.9x32x2.9x
Thu, 26 Dec 2024US$63.4tUS$22.0tUS$1.9t18.4x32.7x2.9x
Sat, 23 Nov 2024US$62.7tUS$22.0tUS$1.9t19.4x32.5x2.8x
Mon, 21 Oct 2024US$60.9tUS$21.6tUS$1.9t18.7x32.6x2.8x
Wed, 18 Sep 2024US$58.2tUS$21.5tUS$1.9t18.1x31.3x2.7x
Fri, 16 Aug 2024US$56.2tUS$21.5tUS$1.8t17.6x30.4x2.6x
Sun, 14 Jul 2024US$58.2tUS$21.3tUS$1.8t17.4x31.6x2.7x
Tue, 11 Jun 2024US$55.3tUS$21.3tUS$1.8t16.8x30.2x2.6x
Thu, 09 May 2024US$53.9tUS$21.2tUS$1.8t17.3x29.7x2.5x
Sat, 06 Apr 2024US$53.7tUS$21.1tUS$1.8t17.2x29.1x2.5x
Mon, 04 Mar 2024US$53.6tUS$21.1tUS$1.8t16.3x29x2.5x
Wed, 31 Jan 2024US$51.6tUS$21.0tUS$1.7t17.1x29.6x2.5x
Fri, 29 Dec 2023US$50.5tUS$21.0tUS$1.8t16.9x28.7x2.4x
Sun, 26 Nov 2023US$47.6tUS$21.1tUS$1.8t16x27.2x2.3x
Tue, 24 Oct 2023US$44.1tUS$21.0tUS$1.7t14.8x25.7x2.1x
Thu, 21 Sep 2023US$46.4tUS$20.9tUS$1.7t15.5x27x2.2x
Sat, 19 Aug 2023US$46.3tUS$20.9tUS$1.7t15.8x27.2x2.2x
Mon, 17 Jul 2023US$47.7tUS$21.0tUS$1.7t15.5x28.6x2.3x
Wed, 14 Jun 2023US$46.3tUS$21.0tUS$1.7t15.3x27.8x2.2x
Price to Earnings Ratio

27.8x


Total Market Cap: US$46.3tTotal Earnings: US$1.7tTotal Revenue: US$21.0tTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Market Price to Earnings3Y Average 30x202420252026
Current Market PE
  • Investors are relatively neutral on the American market at the moment, indicating that they expect earnings will grow in line with historical growth rates.
  • The market is trading at a PE ratio close to its 3-year average PE ratio of 30.0x.
Past Earnings Growth
  • The earnings for American listed companies have grown 14% per year over the last three years.
  • Revenues for these companies have grown 5.0% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Sector Trends

Which sectors have driven the changes within the U.S. Market?

US Market-2.79%
Energy2.13%
Real Estate1.01%
Consumer Staples0.95%
Healthcare0.81%
Financials0.65%
Utilities-0.52%
Industrials-0.76%
Materials-3.82%
Telecom-4.03%
Tech-5.22%
Consumer Discretionary-6.32%
Sector PE
  • Investors favour the Healthcare sector the most for future growth even though it's trading below its 3-year average PE ratio of 65.5x.
    • The market's confidence is likely because analysts are expecting annual earnings growth of 18.0%, which is higher than its past year's earnings growth of 14.3% per year.
  • The Financials sector is the least preferred by investors for future growth, which is trading close to its 3-year average of 17.6x.
Forecasted Growth
  • Analysts are most optimistic on the Tech sector, expecting annual earnings growth of 22% over the next 5 years.
  • This is better than its past earnings growth rate of 14% per year.
  • In contrast, the Real Estate sector is expected to see its earnings grow by 8.2% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuationSector
MRVL Marvell TechnologyUS$263.4728.5%
+US$51.1b		285.5%PE91.2xTech
JPM JPMorgan ChaseUS$312.374.4%
+US$35.0b		17.6%PB2.4xFinancials
BRK.A Berkshire HathawayUS$733.55k3.2%
+US$32.6b		-0.9%PE14.6xFinancials
WMT WalmartUS$118.882.7%
+US$24.9b		22.0%PE41.6xConsumer Staples
LLY Eli LillyUS$1.13k2.4%
+US$23.6b		47.0%PE39.9xHealthcare
See more

Market Insights

Header cover image
The most anticipated IPO in history lands next week at an expected $1.75 trillion price tag. Part launch business, part Starlink, and increasingly an AI bet — could the SpaceX IPO be carrying a valuation that has no room for error?
Continue reading
Land of the rising yields 📈

Latest News

NVDA
US$205.10
NVIDIA
7D
-2.9%
1Y
44.7%
AVGO
US$385.73
Broadcom
7D
-13.7%
1Y
56.2%
MSFT
US$416.67
Microsoft
7D
-7.5%
1Y
-11.4%
UNH
US$399.47
UnitedHealth Group
7D
5.0%
1Y
31.7%
MRVL
US$263.47
Marvell Technology
7D
28.5%
1Y
285.5%
Seeking Alpha • Jun 05

Marvell: Strong Buy, Nvidia's Trillion-Dollar Call Looks Realistic

Summary Marvell Technology is upgraded to strong buy as AI and data center demand drive robust growth and upwardly revised guidance. MRVL's margin pressure is viewed positively, reflecting a shift to high-demand custom silicon with lower margins but strong dollar profits from hyperscalers. Guidance calls for FY2027 revenue of $11.5B (+40%) and FY2028 revenue of $16.5B (+45%), with accelerating growth and margin recovery expected. My price target rises to $375.28, reflecting higher growth expectations, expanded EV/EBITDA multiple, and MRVL's potential to reach a trillion-dollar valuation. Read the full article on Seeking Alpha
JPM
US$312.37
JPMorgan Chase
7D
4.4%
1Y
17.6%
JNJ
US$232.77
Johnson & Johnson
7D
3.3%
1Y
50.1%
Narrative Update • Jun 04

JNJ: Future Drug Cycle Momentum Is Expected To Drive Returns

Analysts have nudged their price targets for Johnson & Johnson higher, with recent revisions clustering in the mid to high $260s and up to $280, as they point to strong new drug momentum and product cycle strength as key drivers supporting slightly higher revenue growth expectations and a rich future P/E framework. Analyst Commentary Recent research remains broadly constructive on Johnson & Johnson, with several bullish analysts citing product cycle momentum, new drug contributions, and a supportive P/E setup.
GOOGL
US$368.53
Alphabet
7D
-3.1%
1Y
112.2%
MU
US$864.01
Micron Technology
7D
-11.0%
1Y
695.9%
New Narrative • Jun 04

Micron’s AI Crown Sits on a Cycle That Hasn’t Changed

I. Industry and Business Model Analysis Micron Technology (NASDAQ: MU) designs, manufactures, and sells memory chips—primarily DRAM (dynamic random-access memory) and NAND flash storage—and high-bandwidth memory (HBM), a specialized DRAM variant critical for AI accelerators.
WMT
US$118.88
Walmart
7D
2.7%
1Y
22.0%
TSLA
US$391.00
Tesla
7D
-10.3%
1Y
32.5%
Seeking Alpha • Jun 03

How Much Longer Can Musk's Vision Support Tesla's 400x P/E

Summary Tesla trades at a TTM P/E of 400x despite EPS contracting for three consecutive years with no meaningful recovery in sight. Q1 2026 operating margin fell from 5.7% to 4.2% as Tesla pours capital into AI and robotics at the expense of core profitability. CapEx is set to surge from $9B in 2025 to $25B in 2026, pushing free cash flow negative while new revenue streams remain years away. Consensus EPS growth of 22% annually through 2028 is comparable to Alphabet, yet Tesla trades at over seven times Alphabet's P/E multiple. Shareholders are pre-paying for robotaxis, FSD and humanoid robots that don't yet contribute enough to earnings, carrying all the risk today. Read the full article on Seeking Alpha
META
US$593.00
Meta Platforms
7D
-6.2%
1Y
-15.0%
New Narrative • Jun 03

Meta: Nobody Uses AI Better

The thesis in one paragraph Meta is quietly turning the best attention-capture engine ever built into a machine that does not just show you ads, but works out what you will buy next. If that lands, the business stops looking like a media company and starts looking like a toll on commerce itself.
AMZN
US$246.03
Amazon.com
7D
-9.1%
1Y
15.2%
Narrative Update • Jun 03

AMZN: AWS AI Backlog And Anthropic OpenAI Deals Will Support Future Cash Generation

Analysts have nudged the Amazon.com fair value estimate higher to about $313 per share from roughly $308, reflecting updated assumptions for slightly stronger long term revenue growth and margins, ongoing AWS AI backlog momentum, and a Street price target cluster moving toward the low to mid $300s, including a recent Truist increase to $320 tied to large Anthropic and OpenAI partnerships. Analyst Commentary Street research around Amazon.com has been highly active, with a wide cluster of price target revisions and list additions centering in the low to mid US$300s.
BRK.A
US$733,550.00
Berkshire Hathaway
7D
3.2%
1Y
-0.9%
XOM
US$149.92
Exxon Mobil
7D
3.2%
1Y
43.8%
Narrative Update • Jun 02

XOM: Higher Iran Risk Premiums Will Support Future Cash Returns

Exxon Mobil's updated analyst price target edges higher to $169.91 as analysts factor in a tighter oil backdrop, prolonged Iran related supply pressures, and stronger refining cracks. These are reflected in slightly higher revenue growth and profit margin assumptions, alongside a modestly lower future P/E.
LLY
US$1,131.42
Eli Lilly
7D
2.4%
1Y
47.0%